Hudson Bay Capital Management LP lifted its stake in The Clorox Company (NYSE:CLX - Free Report) by 35.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 79,857 shares of the company's stock after buying an additional 20,766 shares during the quarter. Hudson Bay Capital Management LP owned approximately 0.06% of Clorox worth $12,970,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. California Public Employees Retirement System boosted its stake in shares of Clorox by 1.3% in the fourth quarter. California Public Employees Retirement System now owns 565,810 shares of the company's stock worth $91,893,000 after buying an additional 6,987 shares during the last quarter. Deutsche Bank AG raised its holdings in Clorox by 14.0% in the 4th quarter. Deutsche Bank AG now owns 654,198 shares of the company's stock worth $106,248,000 after purchasing an additional 80,189 shares during the period. Fifth Third Wealth Advisors LLC acquired a new position in Clorox in the 4th quarter worth about $204,000. Apollon Wealth Management LLC raised its holdings in Clorox by 119.6% in the 4th quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company's stock worth $546,000 after purchasing an additional 1,832 shares during the period. Finally, Miracle Mile Advisors LLC acquired a new position in Clorox in the 4th quarter worth about $1,566,000. Hedge funds and other institutional investors own 78.53% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently weighed in on the company. Wells Fargo & Company reduced their price target on Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Barclays reduced their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a report on Wednesday, May 7th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. DA Davidson reduced their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Finally, UBS Group reduced their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Clorox has an average rating of "Hold" and a consensus target price of $151.23.
View Our Latest Analysis on CLX
Insider Buying and Selling
In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the transaction, the director now owns 4,000 shares of the company's stock, valued at approximately $546,280. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is currently owned by company insiders.
Clorox Price Performance
Shares of CLX stock traded up $1.32 during trading hours on Friday, reaching $136.31. The company had a trading volume of 3,182,936 shares, compared to its average volume of 1,321,018. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a fifty day moving average of $141.05 and a 200-day moving average of $153.32. The company has a market capitalization of $16.80 billion, a price-to-earnings ratio of 37.24, a PEG ratio of 2.62 and a beta of 0.60. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. Clorox's revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter last year, the company earned $1.71 earnings per share. On average, equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were given a $1.22 dividend. The ex-dividend date was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.58%. Clorox's payout ratio is 87.61%.
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
